MktsMarkets

Maravai LifeSciences Holdings, Inc.
NASDAQ: MRVIKey statistics
MRVI News
Stories mentioning MRVI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 65,837 | 49,866 | 41,630 | 47,397 | 46,850 | 56,558 | 69,025 | 69,423 |
| Cost of Goods Sold | 32,136 | 37,024 | 35,975 | 39,629 | 39,125 | 37,168 | 36,791 | 38,582 |
| Gross Profit | 33,701 | 12,842 | 5,655 | 7,768 | 7,725 | 19,390 | 32,234 | 30,841 |
| Operating Expenses | ||||||||
| Research & Development | 3,889 | 3,788 | 3,844 | 4,882 | 4,888 | 4,561 | 4,704 | 4,924 |
| Sales General & Admin | 29,092 | 31,583 | 35,396 | 38,575 | 39,564 | 41,243 | 39,087 | 40,556 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (2,158) | (58,795) | (41,031) | (66,278) | (49,162) | (37,702) | (165,614) | (13,440) |
| Interest Income | 1,873 | 2,384 | 2,797 | 3,030 | 3,225 | 6,036 | 7,071 | 7,086 |
| Interest Expense | 13,634 | 11,939 | ||||||
| Other Expense | (494.00) | (43.00) | (71.00) | (4,062) | 24.00 | 43.00 | 72.00 | (2,562) |
| Pretax Income | (6,528) | (63,009) | (45,149) | (74,125) | (52,691) | (46,074) | (172,144) | (20,855) |
| Tax Provision | (151.00) | 6.00 | (92.00) | (4,288) | 162.00 | (7.00) | 311.00 | (2,435) |
| Net Income (Loss) | (3,733) | (35,681) | (25,556) | (39,591) | (29,945) | (25,905) | (97,074) | (9,789) |
| Earnings Per Share (Basic) | (0.02) | (0.25) | (0.18) | (0.27) | (0.21) | (0.19) | (0.68) | (0.07) |
| Earnings Per Share (Diluted) | (0.02) | (0.25) | (0.18) | (0.27) | (0.21) | (0.19) | (0.68) | (0.07) |
| Weighted Average Shares Outstanding (Basic) | 146,426 | 144,360 | 144,683 | 144,236 | 143,425 | 137,906 | 141,555 | 135,842 |
| Weighted Average Shares Outstanding (Diluted) | 146,426 | 144,360 | 144,683 | 144,236 | 143,425 | 137,906 | 141,555 | 135,842 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MRVI
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a stock listed on the Nasdaq Stock Market under the ticker symbol MRVI. It last traded at $7.57 (Oct 21, 2026, 4:00 PM ET), up 5.1% on the day. That gives Maravai LifeSciences a market capitalisation of $2.0B.
Over the past 52 weeks MRVI has traded between $2.54 and $9.42.
Revenue for the quarter ended Mar 31, 2026 was $65.8M; a net loss of $3.7M. Revenue was up 40.5% from $46.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $65.8M | -$3.7M | -5.7% |
| Dec 31, 2025 | $49.9M | -$35.7M | -71.6% |
| Sep 30, 2025 | $41.6M | -$25.6M | -61.4% |
| Jun 30, 2025 | $47.4M | -$39.6M | -83.5% |
From Maravai LifeSciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…